会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Irreversibly-inactivated pepsinogen fragments for modulating immune function
    • 不可逆失活的胃蛋白酶原片段用于调节免疫功能
    • US08309072B2
    • 2012-11-13
    • US12487637
    • 2009-06-18
    • Harry H. Zhabilov
    • Harry H. Zhabilov
    • A01N63/00A61K38/00
    • A61K38/488A61K38/2013A61K39/39A61K2300/00
    • Isolated anti-cancer peptides are disclosed which are characterized by the amino acid sequences TLTSGGGAIALPPSMAAPPLGPVAPLTGAIHAPTXG (SEQ ID NO: 1); TLSTATGGAIPPVAAMPPGLVAPTHGPAIHP (SEQ ID NO: 2); CCATSGPCGAVMILTPHLTA (SEQ ID NO: 5); MTLTTGSGAIAPAMPPGLPPHTGAIHAPM (SEQ ID NO: 4); and NXVPVSVEGYXQITLDSITX (SEQ ID NO: 3) and a significant in vitro binding affinity for gp96. The peptides exhibit anti-tumor, anti-cancer activity in vivo. Also disclosed is an isolated antiviral peptide characterized by the amino acid sequence GDEPLENYLDTEYF (SEQ ID NO: 6) and a significant in vitro binding affinity for HIV-1 gp 120 and gp 41, and human CD4 cells. The peptide exhibits anti-retroviral activity in vivo, particularly anti-HIV-1 activity.
    • 公开了分离的抗癌肽,其特征在于氨基酸序列TLTSGGGAIALPPSMAAPPLGPVAPLTGAIHAPTXG(SEQ ID NO:1); TLSTATGGAIPPVAAMPPGLVAPTHGPAIHP(SEQ ID NO:2); CCATSGPCGAVMILTPHLTA(SEQ ID NO:5); MTLTTGSGAIAPAMPPGLPPHTGAIHAPM(SEQ ID NO:4); 和NXVPVSVEGYXQITLDSITX(SEQ ID NO:3)和对gp96的显着体外结合亲和力。 肽在体内表现出抗肿瘤,抗癌活性。 还公开了以氨基酸序列GDEPLENYLDTEYF(SEQ ID NO:6)为特征的分离的抗病毒肽和对HIV-1 gp120和gp41以及人CD4细胞的显着体外结合亲和力。 肽在体内表现出抗逆转录病毒活性,特别是抗HIV-1活性。